Elanco Animal Health Inc. | Mid-cap | Healthcare
$14.43
1.05%
| Elanco Animal Health Stock Comparison:
Elanco Animal Health vs ZoetisElanco Animal Health vs Haleon Plc - ADRElanco Animal Health vs Regencell BioscienceElanco Animal Health vs Lantheus HoldingsElanco Animal Health vs Alkermes plcElanco Animal Health vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 4.4B
Gross Profit 2.4B 54.88%
Operating Income 251.0M 5.65%
Net Income 338.0M 7.61%
EPS (Diluted) $0.68

Balance Sheet Metrics

Total Assets 12.6B
Total Liabilities 6.5B
Shareholders Equity 6.1B
Debt to Equity 1.07

Cash Flow Metrics

Operating Cash Flow 1.1B
Free Cash Flow 380.0M

Revenue & Profitability Trend

Elanco Animal Health Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 4.4B 4.4B 4.4B 4.8B 3.3B
Cost of Goods Sold 2.0B 1.9B 1.9B 2.1B 1.7B
Gross Profit 2.4B 2.5B 2.5B 2.6B 1.6B
Research & Development 344.0M 327.0M 321.0M 369.0M 329.0M
Selling, General & Administrative 1.3B 1.3B 1.3B 1.4B 997.0M
Other Operating Expenses 527.0M 548.0M 528.0M 556.0M 360.0M
Total Operating Expenses 2.2B 2.2B 2.1B 2.3B 1.7B
Operating Income 251.0M 326.0M 384.0M 304.0M -82.0M
Pre-tax Income 488.0M -1.2B -72.0M -571.0M -677.0M
Income Tax 150.0M 36.0M 6.0M -88.0M -103.0M
Net Income 338.0M -1.2B -78.0M -483.0M -574.0M
EPS (Diluted) $0.68 -$2.50 -$0.15 -$0.97 -$1.27

Income Statement Trend

Elanco Animal Health Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 3.2B 3.4B 3.3B 3.3B 3.4B
Non-Current Assets 9.4B 11.0B 12.2B 13.2B 14.3B
Total Assets 12.6B 14.4B 15.5B 16.5B 17.7B
Liabilities
Current Liabilities 1.3B 1.2B 1.7B 1.6B 2.1B
Non-Current Liabilities 5.2B 6.9B 6.5B 7.3B 7.1B
Total Liabilities 6.5B 8.1B 8.2B 9.0B 9.2B
Equity
Total Shareholders Equity 6.1B 6.2B 7.3B 7.5B 8.5B

Balance Sheet Composition

Elanco Animal Health Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 338.0M -1.2B -78.0M -483.0M -574.0M
Operating Cash Flow 1.1B -803.0M 351.0M 138.0M 29.1M
Investing Activities
Capital Expenditures -147.0M -140.0M -171.0M -159.0M -63.0M
Investing Cash Flow 1.2B -155.0M -166.0M -492.0M -4.6B
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -1.5B -83.0M -799.0M 460.0M 5.0B
Free Cash Flow 380.0M 117.0M 268.0M 286.0M -352.0M

Cash Flow Trend

Elanco Animal Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.80
Forward P/E 14.20
Price to Book 1.04
Price to Sales 1.50
PEG Ratio 14.20

Profitability Ratios

Profit Margin 8.43%
Operating Margin 10.14%
Return on Equity 6.01%
Return on Assets 1.14%

Financial Health

Current Ratio 2.71
Debt to Equity 69.18
Beta 1.68

Per Share Data

EPS (TTM) $0.75
Book Value per Share $12.80
Revenue per Share $8.95

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
elan 6.6B 17.80 1.04 6.01% 8.43% 69.18
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Regencell Bioscience 18.5B - 1,394.12 -43.18% 0.00% 1.04
Lantheus Holdings 5.6B 23.07 4.81 24.11% 16.55% 52.78
Alkermes plc 4.8B 13.93 3.19 25.71% 23.30% 4.90

Financial data is updated regularly. All figures are in the company's reporting currency.